Published online before print July 18, 2002, doi: 10.1161/01.RES.0000029969.39875.4B
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 12, 2002
Revised on July 8, 2002
Accepted on July 8, 2002
Inactivation of Enhanced Expression of Gi Proteins by Pertussis Toxin Attenuates the Development of High Blood Pressure in Spontaneously Hypertensive Rats
Yuan Li and Madhu B. Anand-Srivastava *
From the Department of Physiology and Groupe de Recherche sur le Système Nerveux Autonome, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.
* To whom correspondence should be addressed. E-mail: anandsrm{at}physio.umontreal.ca.
We have previously shown that the enhanced expression of Gi proteins in spontaneously hypertensive rats (SHR) that precedes the development of high blood pressure may be one of the contributing factors in the pathogenesis of hypertension. In the present study, we demonstrate that the inactivation of Gi proteins by intraperitoneal injection of pertussis toxin (PT, 1.5 µg/100 g body wt) into 2-week-old prehypertensive SHR prevented the development of hypertension up to 4 weeks and that, thereafter, it started to increase and reached the same level found in untreated SHR after 6 weeks. A second injection of PT after 4 weeks delayed the increase in blood pressure for another week. The PT-induced decrease in blood pressure in 6-week-old SHR was associated with a decreased level of Gi
-2 and Gi-3 proteins in the heart, as determined by in vitro ADP ribosylation and immunoblotting. The decreased level of Gi proteins was reflected in decreased Gi functions. Furthermore, an augmentation of blood pressure to the same level in PT-treated SHR as found in untreated SHR was associated with enhanced expression and function of Gi. These results indicate that the inactivation of Gi proteins by PT treatment in prehypertensive SHR attenuates the development of hypertension and suggest that the enhanced levels of Gi proteins that result in the decreased levels of cAMP and associated impaired cellular functions may be contributing factors in the pathogenesis of hypertension in SHR.
Key words: pertussis toxin • ADP ribosylation • G proteins • blood pressure • spontaneously hypertensive rats
This article has been cited by other articles:
 |
|
 |
|
  M. Arejian, Y. Li, and M. B. Anand-Srivastava Nitric oxide attenuates the expression of natriuretic peptide receptor C and associated adenylyl cyclase signaling in aortic vascular smooth muscle cells: role of MAPK Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1859 - H1867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Teres, G. Barcelo-Coblijn, M. Benet, R. Alvarez, R. Bressani, J. E. Halver, and P. V. Escriba Oleic acid content is responsible for the reduction in blood pressure induced by olive oil PNAS, September 16, 2008; 105(37): 13811 - 13816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Blumer, K. Lord, T. L. Saunders, A. Pacchioni, C. Black, E. Lazartigues, K. J. Varner, T. W. Gettys, and S. M. Lanier Activator of G Protein Signaling 3 Null Mice: I. Unexpected Alterations in Metabolic and Cardiovascular Function Endocrinology, August 1, 2008; 149(8): 3842 - 3849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Tawar, K. Kotlo, S. Jain, S. Shukla, S. Setty, and R. S. Danziger Renal Phosphodiesterase 4B Is Activated in the Dahl Salt-Sensitive Rat Hypertension, March 1, 2008; 51(3): 762 - 766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Dubinion, Z. Mi, and E. K. Jackson Role of Renal Sympathetic Nerves in Regulating Renovascular Responses to Angiotensin II in Spontaneously Hypertensive Rats J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1330 - 1336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Dubinion, Z. Mi, C. Zhu, L. Gao, and E. K. Jackson Pancreatic Polypeptide-Fold Peptide Receptors and Angiotensin II-Induced Renal Vasoconstriction Hypertension, March 1, 2006; 47(3): 545 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Wettschureck and S. Offermanns Mammalian G Proteins and Their Cell Type Specific Functions Physiol Rev, October 1, 2005; 85(4): 1159 - 1204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Keys, R.-H. Zhou, D. M. Harris, C. A. Druckman, and A. D. Eckhart Vascular Smooth Muscle Overexpression of G Protein-Coupled Receptor Kinase 5 Elevates Blood Pressure, Which Segregates With Sex and Is Dependent on Gi-Mediated Signaling Circulation, August 23, 2005; 112(8): 1145 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. MacDonnell, H. Kubo, D. L. Crabbe, B. F. Renna, P. O. Reger, J. Mohara, L. A. Smithwick, W. J. Koch, S. R. Houser, and J. R. Libonati Improved Myocardial {beta}-Adrenergic Responsiveness and Signaling With Exercise Training in Hypertension Circulation, June 28, 2005; 111(25): 3420 - 3428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li, S. Hashim, and M. B. Anand-Srivastava Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells Cardiovasc Res, June 1, 2005; 66(3): 503 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. C. Kopp and M. Z. Cicha Impaired substance P release from renal sensory nerves in SHR involves a pertussis toxin-sensitive mechanism Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2004; 286(2): R326 - R333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. El-Armouche, O. Zolk, T. Rau, and T. Eschenhagen Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure Cardiovasc Res, December 1, 2003; 60(3): 478 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gao, C. Zhu, and E. K. Jackson alpha 2-Adrenoceptors Potentiate Angiotensin II- and Vasopressin-Induced Renal Vasoconstriction in Spontaneously Hypertensive Rats J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 581 - 586. [Abstract] [Full Text] [PDF]
|
|